Sara Pilotto

5.6k total citations · 1 hit paper
187 papers, 2.9k citations indexed

About

Sara Pilotto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sara Pilotto has authored 187 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Oncology, 93 papers in Pulmonary and Respiratory Medicine and 34 papers in Molecular Biology. Recurrent topics in Sara Pilotto's work include Lung Cancer Treatments and Mutations (74 papers), Cancer survivorship and care (36 papers) and Lung Cancer Research Studies (32 papers). Sara Pilotto is often cited by papers focused on Lung Cancer Treatments and Mutations (74 papers), Cancer survivorship and care (36 papers) and Lung Cancer Research Studies (32 papers). Sara Pilotto collaborates with scholars based in Italy, Spain and United States. Sara Pilotto's co-authors include Emilio Bria, Michèle Milella, Giampaolo Tortora, Luisa Carbognin, Aldo Scarpa, Alice Avancini, Isabella Sperduti, Ilaria Trestini, Matteo Brunelli and Daniela Tregnago and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sara Pilotto

167 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Luisa Carbognin, Sara Pilotto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Pilotto Italy	29	1.8k	1.1k	813	485	324	187	2.9k
Giannis Mountzios Greece	30	1.6k 0.9×	971 0.9×	1.0k 1.2×	507 1.0×	156 0.5×	124	3.2k
Masashi Ando Japan	31	2.0k 1.1×	954 0.9×	688 0.8×	774 1.6×	204 0.6×	206	3.6k
Aurelius Omlin Switzerland	32	1.3k 0.7×	1.9k 1.7×	816 1.0×	985 2.0×	325 1.0×	115	3.6k
Stefania Gori Italy	30	2.0k 1.1×	897 0.8×	680 0.8×	694 1.4×	234 0.7×	180	3.5k
Vincent Chung United States	30	2.3k 1.3×	631 0.6×	897 1.1×	830 1.7×	243 0.8×	169	3.6k
Yuanyuan Zhao China	29	1.9k 1.0×	1.1k 1.0×	558 0.7×	533 1.1×	251 0.8×	162	3.0k
Saverio Cinieri Italy	32	2.5k 1.4×	930 0.9×	1.0k 1.2×	957 2.0×	412 1.3×	206	4.3k
Andrew Haydon Australia	28	1.9k 1.1×	464 0.4×	751 0.9×	269 0.6×	232 0.7×	143	3.1k
Brett Hughes Australia	31	2.3k 1.3×	2.1k 1.9×	820 1.0×	696 1.4×	639 2.0×	179	4.4k
Pavlos Msaouel United States	31	1.1k 0.6×	1.1k 1.0×	989 1.2×	515 1.1×	484 1.5×	225	3.4k

Countries citing papers authored by Sara Pilotto

Since Specialization

Citations

This map shows the geographic impact of Sara Pilotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pilotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pilotto more than expected).

Fields of papers citing papers by Sara Pilotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Pilotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pilotto. The network helps show where Sara Pilotto may publish in the future.

Co-authorship network of co-authors of Sara Pilotto

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Pilotto. A scholar is included among the top collaborators of Sara Pilotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Pilotto. Sara Pilotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tregnago, Daniela, Lucia Longo, Marco Sposito, et al.. (2025). Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report. Frontiers in Oncology. 15. 1672319–1672319.

Newton, Robert U., Chris Bishop, Luca Maestroni, et al.. (2025). Periodizing Exercise Medicine Prescription for Patients with Cancer: A Narrative Opinion. Sports Medicine. 55(12). 2987–2999.

Taaffe, Dennis R., Alice Avancini, Sara Pilotto, et al.. (2025). Effects of exercise on inflammation in female survivors of nonmetastatic breast cancer: a systematic review and meta-analysis. JNCI Journal of the National Cancer Institute. 117(10). 1984–1998. 8 indexed citations

Belluomini, Lorenzo, Marco Sposito, Michèle Milella, et al.. (2024). What is the role of physical exercise in the era of cancer prehabilitation? A systematic review. Critical Reviews in Oncology/Hematology. 198. 104350–104350. 8 indexed citations

Bria, Emilio, José Luís Costa, Claudio Sini, et al.. (2024). 1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database. Annals of Oncology. 35. S818–S818. 1 indexed citations

Belluomini, Lorenzo, Alice Avancini, Ilaria Trestini, et al.. (2024). Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers. Clinical Nutrition Open Science. 55. 168–172. 1 indexed citations

Belluomini, Lorenzo, Alice Avancini, Marco Sposito, et al.. (2024). Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success. Critical Reviews in Oncology/Hematology. 201. 104444–104444. 4 indexed citations

Pasello, Giulia, Alessandro Del Conte, Fabiana Letizia Cecere, et al.. (2024). Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. The Oncologist. 29(7). 596–608. 2 indexed citations

Giannarelli, Diana, Lorenzo Belluomini, Ilaria Trestini, et al.. (2024). Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study. Healthcare. 12(16). 1643–1643. 1 indexed citations

10.

Ferrara, Miriam Grazia, Lorenzo Belluomini, Marco Sposito, et al.. (2023). Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors. Critical Reviews in Oncology/Hematology. 184. 103929–103929. 14 indexed citations

11.

Belluomini, Lorenzo, Marco Sposito, Alice Avancini, et al.. (2023). Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates. Cancers. 15(22). 5368–5368. 19 indexed citations

12.

Sposito, Marco, Lorenzo Belluomini, Daniela Tregnago, et al.. (2023). Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories. Journal of Personalized Medicine. 13(10). 1427–1427. 2 indexed citations

13.

Avancini, Alice, Carlo Ferri Marini, Isabella Sperduti, et al.. (2022). Kinesiology Students’ Perception Regarding Exercise Oncology: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 19(13). 7724–7724. 1 indexed citations

14.

Ferrara, Miriam Grazia, Vincenzo Di Noia, Ettore D’Argento, et al.. (2020). Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives. Cancers. 12(5). 1196–1196. 63 indexed citations

15.

Avancini, Alice, Valeria Pala, Ilaria Trestini, et al.. (2020). Exercise Levels and Preferences in Cancer Patients: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 17(15). 5351–5351. 63 indexed citations

16.

Piro, Geny, Carmine Carbone, Luisa Carbognin, et al.. (2019). Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story. Cancers. 11(10). 1525–1525. 30 indexed citations

17.

Maso, Alessandro Dal, Elisa Roca, Sara Pilotto, et al.. (2019). Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy. Clinical Lung Cancer. 21(1). 1–14.e3. 19 indexed citations

18.

Γκουντάκος, Αναστάσιος, Giulia Sartori, Italia Falcone, et al.. (2019). PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around. Cancers. 11(8). 1141–1141. 83 indexed citations

19.

Trestini, Ilaria, Luisa Carbognin, Alessandro De Toma, et al.. (2018). Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. Critical Reviews in Oncology/Hematology. 129. 54–66. 38 indexed citations

20.

Noia, Vincenzo Di, Ettore D’Argento, Sara Pilotto, et al.. (2018). Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies. Expert Opinion on Biological Therapy. 18(9). 937–945. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact